1. Home
  2. XENE vs CSTM Comparison

XENE vs CSTM Comparison

Compare XENE & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$55.97

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$24.69

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XENE
CSTM
Founded
1996
2010
Country
Canada
France
Employees
N/A
11500
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
XENE
CSTM
Price
$55.97
$24.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$67.25
$29.00
AVG Volume (30 Days)
1.4M
2.7M
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
405.26
EPS
N/A
1.92
Revenue
$311,000.00
$8,449,000,000.00
Revenue This Year
N/A
$21.45
Revenue Next Year
$2,823.63
$0.62
P/E Ratio
N/A
$12.77
Revenue Growth
N/A
15.19
52 Week Low
$26.74
$7.33
52 Week High
$62.91
$27.41

Technical Indicators

Market Signals
Indicator
XENE
CSTM
Relative Strength Index (RSI) 65.62 49.57
Support Level $38.36 $24.00
Resistance Level N/A $27.33
Average True Range (ATR) 2.41 1.17
MACD 1.56 -0.26
Stochastic Oscillator 67.32 19.06

Price Performance

Historical Comparison
XENE
CSTM

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About CSTM Constellium SE (France)

Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.

Share on Social Networks: